SUMMATION BIO
Summation Bio is a gene therapy company that develops a novel non-viral gene transfer technology. The company was founded in 2018 and is headquartered in Somerville, Massachusetts, United States.
SUMMATION BIO
Industry:
Biotechnology Genetics Therapeutics
Founded:
2018-01-01
Address:
Somerville, Massachusetts, United States
Country:
United States
Status:
Active
Contact:
617-863-3650
Total Funding:
24.46 M USD
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Dimension Therapeutics
Dimension Therapeutics is a gene therapy company developing novel treatments for rare diseases.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
More informations about "Summation Bio"
What Happened To Summation Bio & Why Did It Fail?
What Happened to Summation Bio? The rise and fall of Summation Bio is a story marked by significant milestones and challenges: Initial Funding and Ambitions: Summation Bio raised …See details»
Summation Bio - PitchBook
Summation Bio was founded in 2018. Where is Summation Bio headquartered? Summation Bio is headquartered in Somerville, MA. What industry is Summation Bio in? Summation Bio’s …See details»
Summation Bio - Products, Competitors, Financials, Employees ...
Summation Bio is a biotechnology company that develops gene transfer technology intended to address the needs in delivering large-sized DNA, and RNA to multiple cell types. Its mini …See details»
Summation Bio - Funding, Financials, Valuation & Investors
Summation Bio is a gene therapy company that develops a novel non-viral gene transfer technology. New. Resources. ... Experience the new Crunchbase, powered by AI . Experience …See details»
Summation Bio, Inc. - Drug pipelines, Patents, Clinical trials
RA Capital-backed non-viral gene therapy startup Summation Bio to shut down. As a string of new gene therapy startups aims to create treatments without the go-to shuttling method of an AAV …See details»
Summation Bio - Updates, News, Events, Signals & Triggers
Apr 12, 2022 Organization. Summation Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Research and Development Insight …See details»
RA Capital-backed non-viral gene therapy startup Summation Bio …
May 31, 2023 RA Capital-backed non-viral gene therapy startup Summation Bio to shut down. ... Leerink’s David Risinger on the market shock and hits to biopharma April 7, 2025; …See details»
Summation Bio, Inc. Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Summation Bio, Inc.. See Summation Bio, Inc. company profile and funding data.See details»
Summation Bio - Raised $24.5M Funding from investors - Tracxn
Mar 30, 2025 Summation Bio raised $24.5M in its latest funding round, which was Series B round held on Apr 04, 2022. How much funding has Summation Bio raised till date? …See details»
Summation Bio, Inc. (Summation Bio, Inc.) - 药物管线_专利_临床试 …
May 31, 2023 Summation Bio, backed by at least $24 million in Series A funds, is “terminating operations” next month, per an employee’s LinkedIn profile update. (According to their …See details»
Summation Bio, Inc.:Company Profile & Technical …
Summation Bio, Inc. was founded in 2018. Summation Bio, Inc. has a total of 27 patents . Related Topics. Gene Summation. Login to view all basic info. Data Snapshot. 27. Patent. 1. Funding. …See details»
Summation Bio, Inc. - fund raising filing - Form Ds
Apr 5, 2022 Summation Bio, Inc. - Most recent fund raising on April 5, 2022 raised $24,462,489 in EquitySee details»
SUMMATION BIO INC Somerville MA, 02143 - Company Profile
Free Business profile for SUMMATION BIO INC at 519 Somerville Ave, Somerville, MA, 02143-3238, US. SUMMATION BIO INC specializes in: Business Services, N.E.C.. This business can …See details»
What is Summation Bio? Company Culture, Mission, Values
See what employees say it's like to work at Summation Bio. Salaries, reviews, and more - all posted by employees working at Summation Bio.See details»
Summation Bio - Crunchbase
Summation Bio is a gene therapy company that develops a novel non-viral gene transfer technology. New. Resources. Advanced Search. Start Free Trial ... Experience the new …See details»
Summation Bio-动脉网 - vbdata.cn
Jan 1, 2018 Summation Bio是一家基因治疗公司，开发了一种新的非病毒基因转移技术。旨在解决向多种细胞类型输送大尺寸DNA和RNA的未满足需求。该公司的微核小体技术能够实现高 …See details»
US20210395303A1 - Mini-nucleosome core proteins and use in …
Summation Bio Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of …See details»
Summation Bio - Tech Stack, Apps, Patents & Trademarks
Summation Bio is a gene therapy company that develops a novel non-viral gene transfer technology. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
Series A - Summation Bio - 2022-04-04 - Crunchbase
Apr 4, 2022 Organization Name . Summation Bio . Announced Date Apr 4, 2022; Funding Type Series A; Funding Stage Early Stage Venture; Money Raised . obfuscated. obfuscated. …See details»
Biodiversity change is more than the sum of its parts
6 days ago Biodiversity change is more than the sum of its parts Download PDF. Journal Club; Published: 14 April 2025 ... Department of Biology, McGill University, Montreal, Quebec, Canada.See details»